FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
China Health Industries Holdings, Inc. Stock AnalysisComprehensive stock analysis for China Health Industries Holdings, Inc. (CHHE) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCHHE
CHHE
China Health Industries Holdings, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CHHE
Home🔹Stocks🔹China Health Industries Holdings, Inc.

China Health Industries Holdings, Inc.

🇺🇸CHHE•OTC

China Health Industries Holdings, Inc.

🇺🇸CHHE•OTC
Market cap
$6.55K
Sentiment

Your view on CHHE

Mkt Cap
$6.55K
Sentiment
Your view
CHHE
China Health Industries Holdings, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CHHE
Company Overview

Overview

What the company does, where it operates, and who runs it.

About China Health Industries Holdings, Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Sun Xin
Headquarters
3199-1 Longxiang Road, Harbin, CN
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Sun Xin
Headquarters
3199-1 Longxiang Road, Harbin, CN
Description

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products.

It offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, and hemp frozen age nourishing creams.

The company also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand.

In addition, it offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements.

Further, the company manufactures and sells various types of medical drugs. It primarily sells its products through sales agents. China Health Industries Holdings, Inc. is based in Harbin City, the People's Republic of China.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for China Health Industries Holdings, Inc., and the rating behind it. CHHE last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for China Health Industries Holdings, Inc.. Starting points for China Health Industries Holdings, Inc.: EPS -$0.0062, beta -20.54 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for China Health Industries Holdings, Inc.. China Health Industries Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for China Health Industries Holdings, Inc.. Trailing twelve-month EPS for China Health Industries Holdings, Inc. stands at -$0.0062. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for China Health Industries Holdings, Inc.. China Health Industries Holdings, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

China Health Industries Holdings, Inc. valued side by side against its closest peers. China Health Industries Holdings, Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold China Health Industries Holdings, Inc., and how their positions are changing. At a $6,554 market value, institutional positions materially move China Health Industries Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by China Health Industries Holdings, Inc. executives and directors. Shares of China Health Industries Holdings, Inc. have traded between $0.0001 and $0.22 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming China Health Industries Holdings, Inc.. China Health Industries Holdings, Inc. is a $6,554 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming China Health Industries Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for China Health Industries Holdings, Inc.. Coverage tracks China Health Industries Holdings, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BQST — BioQuest Corp.
  • ECGS — Eco-Growth Strategies Inc.
  • LUFFF — Herbal Dispatch Inc.
  • MCUJF — Medicure Inc.
  • MYCOF — Noveris Health Sciences Inc.
  • NUMIF — Numinus Wellness Inc.
  • TRUFF — Red Light Holland Corp.

More Drug Manufacturers - Specialty & Generic companies

  • IPSEY — Ipsen S.A.
  • IRWD — Ironwood Pharmaceuticals, Inc.
  • ISCNF — Isracann Biosciences Inc.
  • ISOLF — Isodiol International Inc.
  • ITHUF — iAnthus Capital Holdings, Inc.
  • IVIXF — Invion Limited
  • IVX.AX — Invion Limited
  • JUSH.CN — Jushi Holdings Inc.
  • JUVAF — Juva Life Inc.
  • JWCAF — James E. Wagner Cultivation Corporation
  • KALY — Kali, Inc.
  • KAYS — Kaya Holdings, Inc.

News

Latest Market News